• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Marsh & McLennan Companies (MRSH) Reported Second Quarter Earnings, Is It Still Below Fair Value?

    Simply Wall St·07/28/2026 10:25:53
    語音播報

    Marsh & McLennan Companies (MRSH) reported second quarter 2026 earnings on July 21, with sales of US$7,404 million and net income of US$1,266 million compared with the prior year period.

    See our latest analysis for Marsh & McLennan Companies.

    Marsh & McLennan Companies has seen a 30 day share price return of 8.45% and a 90 day share price return of 7.31%, while the 1 year total shareholder return is down 9.31%. This points to improving short term momentum alongside a softer longer term picture.

    If you are comparing Marsh & McLennan Companies with other ideas, this is a good moment to see what else is gaining attention through the Simply Wall St screener for 18 top founder-led companies

    After Marsh & McLennan Companies' recent share price rebound and the current gap between its market price, analyst targets and intrinsic estimate, the key issue now is where fair value really sits for this stock.

    Most Popular Narrative: 10.5% Undervalued

    Marsh & McLennan Companies last closed at $183.31, while the most followed narrative pegs fair value at $204.86, using a 7.11% discount rate. That gap is built on a specific view of how earnings and margins might develop over the next few years.

    Strategic investments in digital transformation, advanced analytics, and AI (e.g., proprietary data tools for risk modeling, agentic interfaces) are expected to enhance operational efficiency and improve product/service offerings, enabling margin expansion and net earnings growth through improved client retention and lower cost to serve.

    Read the complete narrative. Read the complete narrative.

    Curious what sits behind that margin story for Marsh & McLennan Companies? The narrative leans on steady revenue gains, wider profitability, and a premium future earnings multiple. The assumptions are detailed, but the key inputs are not obvious at first glance. If you want to see exactly how those moving parts support a fair value above $200, the full breakdown lays it out step by step.

    Result: Fair Value of $204.86 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, investors still need to watch for sustained pricing pressure in property and reinsurance, along with weaker consulting demand, which could challenge the Marsh & McLennan Companies margin story.

    Find out about the key risks to this Marsh & McLennan Companies narrative.

    Another View On Marsh & McLennan Companies Valuation

    While the fair value narrative points to Marsh & McLennan Companies as 10.5% undervalued at $204.86, the P/E picture is less generous. The stock trades at about 22x earnings versus a fair ratio of 13.7x and a US Insurance industry average of 12.4x, which suggests valuation risk if sentiment cools.

    Peers closer to 24.6x point to some support for the current pricing. Investors still face a trade off between paying up for perceived quality and the possibility that the market drifts back toward the fair ratio. Which side of that gap do you think will matter most over your holding period?

    See what the numbers say about this price — find out in our valuation breakdown.

    NYSE:MRSH P/E Ratio as at Jul 2026
    NYSE:MRSH P/E Ratio as at Jul 2026

    Next Steps

    The mix of positives and concerns around Marsh & McLennan Companies is clear, so it makes sense to review the data now and decide where you stand. To weigh both sides, take a close look at the 3 key rewards and 2 important warning signs.

    Looking for more investment ideas beyond Marsh & McLennan Companies?

    If Marsh & McLennan Companies caught your attention, do not stop there. Broaden your watchlist now so you are not relying on a single opportunity.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.